Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9972114 | 0.95 | MEN1 (0.50) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL13522676 | 0.95 | MEN1 (0.50) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL13309557 | 0.95 | TDP1 (0.48) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL2076806 | 0.93 | TDP1 (0.59) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL18082476 | 0.92 | TDP1 (0.45) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL14370702 | 0.91 | MEN1 (0.50) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL18346638 | 0.91 | MEN1 (0.50) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL19000741 | 0.91 | MEN1 (0.50) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL16253819 | 0.89 | TDP1 (0.44) | TDP1TSHRMAPK1ALDH1A1MEN1 | |
| SCHEMBL13471910 | 0.89 | TDP1 (0.64) | TDP1TSHRMAPK1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217418-A1 | SAMPLE PREPARATION FOR NUCLEIC ACIDS | Life Technologies Corporation (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250171424-A1 | Acid-Base Controlled Nano-Bending Lassos to Manipulate Photo-Switching Units in [1]Rotaxanes | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2025-05-29 | — | — | US | claimed |
| CN-104302747-B | Novel low viscosity functional fluid compositions | 巴斯夫欧洲公司 | 2016-12-28 | — | — | CN | claimed |
| CN-101232869-B | The gel combination of topical | WARNER CHILCOTT Co.,LLC (US) | 2016-03-02 | — | — | CN | claimed |
| CN-101237851-B | Estrogen composition for vaginal administration | WARNER CHILCOTT CO LLC | 2013-09-18 | — | — | CN | claimed |
| CN-101237851-A | Estrogen composition for vaginal administration | WARNER CHILCOTT CO INC (US) | 2008-08-06 | — | — | CN | claimed |
| CN-101232869-A | Gel compositions for topical administration | WARNER CHILCOTT CO INC (US) | 2008-07-30 | — | — | CN | claimed |
| US-12564572-B2 | Topical ocular delivery of cromakalim | QLARIS BIO, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12564573-B2 | Topical ocular delivery of cromakalim | QLARIS BIO, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250387366-A1 | TOPICAL OCULAR DELIVERY OF CROMAKALIM | QLARIS BIO, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| CN-113552768-B | Photosensitive coloring composition, color filter and image display device | 爱天思株式会社 | 2025-06-17 | — | — | CN | disclosed |
| US-20250171424-A1 | Acid-Base Controlled Nano-Bending Lassos to Manipulate Photo-Switching Units in [1]Rotaxanes | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2025-05-29 | — | — | US | disclosed |
| EP-4536295-A1 | HYDROGEL-BASED INJECTABLE NANOCOMPOSITE FOR SURGICAL IMAGING | Università Degli Studi Di Verona (IT) | 2025-04-16 | — | — | EP | disclosed |
| CN-1678357-A | Superabsorbent polymer and method of making the same | BASF AG (DE) | 2005-10-05 | — | — | CN | disclosed |
| CN-1649555-A | Absorbent article containing a skin care composition | SCA HYGIENE PROD AB (SE) | 2005-08-03 | — | — | CN | disclosed |
| CN-1606458-A | Superabsorbent polymers containing tocopherol | BASF AG (DE) | 2005-04-13 | — | — | CN | disclosed |
| CN-1561234-A | Highly swellable hydrogels with acid centers | BASF AG (DE) | 2005-01-05 | — | — | CN | disclosed |
| CN-1482924-A | Hydrogels coated with steric or electrostatic spacers | 巴斯福股份公司 | 2004-03-17 | — | — | CN | disclosed |
| EP-0929230-A1 | PROCESS FOR THE FORMATION OF PLASTICIZED PROTEINACEOUS MATERIALS, AND COMPOSITIONS CONTAINING THE SAME | WARNER-LAMBERT COMPANY (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998015189-A1 | PROCESS FOR THE FORMATION OF PLASTICIZED PROTEINACEOUS MATERIALS, AND COMPOSITIONS CONTAINING THE SAME | WARNER-LAMBERT COMPANY (US) | 1998-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387366-A1 | TOPICAL OCULAR DELIVERY OF CROMAKALIM | GK, PSEN1, NEFM | TDP1 2428/4885TSHR 4001/4885MAPK1 4045/4885 |
| US-12564572-B2 | Topical ocular delivery of cromakalim | PRKCZ, GK, PHYKPL | TDP1 3459/4885TSHR 3631/4885MAPK1 3493/4885 |
| US-12564573-B2 | Topical ocular delivery of cromakalim | GK, PRKCZ, PHYKPL | TDP1 3754/4885TSHR 3880/4885MAPK1 3585/4885 |
| US-20250171424-A1 | Acid-Base Controlled Nano-Bending Lassos to Manipulate Photo-Switching Units in [1]Rotaxanes | BICRA, MAP1LC3A, MAP1LC3B | TDP1 3633/4885TSHR 2700/4885MAPK1 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.